The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Solifenacin Clonmel 5 mg film-coated tablets

5 milligram(s) Film-coated tablet

Clonmel Healthcare LtdPA0126/288/001

Main Information

Trade NameSolifenacin Clonmel 5 mg film-coated tablets
Active SubstancesSolifenacin succinate
Strength5 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderClonmel Healthcare Ltd
Licence NumberPA0126/288/001

Group Information

ATC CodeG04BD Drugs for urinary frequency and incontinence
G04BD08 solifenacin

Status

Authorised/WithdrawnAuthorised
Licence Issued28/07/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0116-001-003
Interchangeable List DocumentPDF of Interchangeable List
« Back